— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular and rare diseases —
Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer
Seeking Alpha / 4 minutes ago 1 Views
— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular and rare diseases —
Comments